.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Johnson and Johnson
US Army
Teva
Federal Trade Commission
Moodys
Fish and Richardson
Express Scripts
Harvard Business School

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019536

« Back to Dashboard

NDA 019536 describes INDERAL, which is a drug marketed by Wyeth Ayerst, Wyeth Pharms Inc, and Ani Pharms Inc, and is included in three NDAs. Additional details are available on the INDERAL profile page.

The generic ingredient in INDERAL is propranolol hydrochloride. There are twenty-one drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the propranolol hydrochloride profile page.

Summary for 019536

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antimigraine Agents
Cardiovascular Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrength10MG/ML
Approval Date:Dec 12, 1986TE:RLD:No

Expired Orange Book Patents for NDA: 019536

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth AyerstINDERALpropranolol hydrochlorideSUSPENSION;ORAL019536-001Dec 12, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Citi
Farmers Insurance
Healthtrust
AstraZeneca
Chubb
Chinese Patent Office
Merck
Queensland Health
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot